semaglutide injection middletown compounded COMPOUNDED SEMAGLUTIDE Semaglutide 1.75mg - 4 injections

Developed by Novo Nordisk as a glucagon-like peptide-1 receptor agonist (GLP-1 RA), semaglutide emerged from efforts to create longer-acting diabetes medications with improved glycemic control and potential cardiovascular benefits

Case presentation The patient is a 54-year-old man with a 15-year history of cocaine abuse and a diagnosis of obesity (BMI: 35.4 kg/m 2 , weight: 105 kg)

Any time the vial that arrives looks different from what you expected, verify with your provider before injecting

Your healthcare provider will conduct a thorough assessment to determine whether the taste change is related to Ozempic, another medication, or an underlying condition

Theyre both relatively safe medicines with good safety profiles

As of May 2025, obtaining compounded semaglutide has become significantly restricted